Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma

Gut. 2024 Sep 11:gutjnl-2024-333375. doi: 10.1136/gutjnl-2024-333375. Online ahead of print.
No abstract available

Keywords: HEPATOCELLULAR CARCINOMA; IMMUNOTHERAPY; MACROPHAGES.

Publication types

  • Letter